NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines
Buyers
Value
£33,081,281
Suppliers
- Aguettant Ltd
- Hameln Pharma Ltd
- Fresenius Kabi Ltd
- ACCORD-UK LTD
- Glenmark Pharmaceuticals Europe Ltd
- Teva UK Ltd
- Napp Pharmaceuticals
- Clinimed Limited
- Martindale Pharma
- ASPEN PHARMACARE UK LIMITED
- DRUGSRUS LTD
- Gerot Lannach UK Ltd
- Morningside Pharmaceuticals Limited
- Novumgen Limited
- Qdem Pharmaceuticals
- Wockhardt UK Limited
- Aspire Pharma Ltd
- Sandoz
- Kyowa Kirin International NewCo Ltd
- Janssen Cilag Limited
- Teva UK Limited
- Optimum Medical Solutions
- Mercury Pharmaceuticals Limited
- B. BRAUN MEDICAL LIMITED
- Baxter Healthcare Ltd
- Rosemont Pharmaceuticals Ltd
- Crescent Pharma Limited
- Arcadia Pharma Limited T/A Arcadia Medical
- B. BRAUN MEDICAL LTD
- CST Pharma Ltd
- Day Lewis Medical Ltd
- Ennogen Healthcare Ltd
- GSK UK Limited
- Kent Pharmaceuticals Ltd
- Medreich PLC
- Neon Healthcare
- Pfizer Ltd
- Phoenix Labs
- Piramal CC
- Selective Supplies Ltd
- Thornton & Ross
- Viatris UK Healthcare Ltd
Classifications
- Pharmaceutical products
Tags
- award
- contract
Published
8 months ago
Description
This Framework Agreement is for the supply of Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines to health boards across NHS Scotland. The Goods have been split into twenty (20) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
Similar Contracts
AI Bid Assistant
Our AI-powered tool to help you create winning bids is coming soon!
Timeline complete
Complete